Available to SourceHuman Prescription DrugOncology & Specialty

Ibrance (Palbociclib)

125 mg/1 · Capsule

By Pfizer Laboratories Div Pfizer Inc

Palbociclib · Capsule · 125 mg

NDC: 0069-0189
Route: Oral
Therapeutic class: Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor , Kinase Inhibitors [MoA]
Marketing category: NDA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Ibrance (Palbociclib)

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)